4.7 Review

Therapeutic Manipulation of the HIF Hydroxylases

Journal

ANTIOXIDANTS & REDOX SIGNALING
Volume 12, Issue 4, Pages 481-501

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2009.2711

Keywords

-

Funding

  1. Biotechnology and Biological Sciences Research Council
  2. European Union
  3. Newton-Abraham Fund
  4. Wellcome Trust
  5. Medical Research Council
  6. Deutsche Forschungsgemeinschaft
  7. Medical Research Council [G0500495] Funding Source: researchfish
  8. National Institute for Health Research [ACF-2009-13-013] Funding Source: researchfish

Ask authors/readers for more resources

The hypoxia-inducible factor (HIF) family of transcription factors is responsible for coordinating the cellular response to low oxygen levels in animals. By regulating the expression of a large array of target genes during hypoxia, these proteins also direct adaptive changes in the hematopoietic, cardiovascular, and respiratory systems. They also play roles in pathological processes, including tumorogenesis. In recent years, several oxygenases have been identified as key molecular oxygen sensors within the HIF system. The HIF hydroxylases regulate the stability and transcriptional activity of the HIF-alpha subunit by catalyzing hydroxylation of specific proline and asparaginyl residues, respectively. They require oxygen and 2-oxoglutarate (2OG) as co-substrates, and depend upon non-heme ferrous iron (Fe(II)) as a cofactor. This article summarizes current understanding of the biochemistry of the HIF hydroxylases, identifies targets for their pharmacological manipulation, and discusses their potential in the therapeutic manipulation of the HIF system. Antioxid. Redox Signal. 12, 481-501.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available